GARRETT CAMP: Open Payments
NPI 1649756198 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,385 in 173 payments from 16 companies in 2025. Trend: 2023 $2,623 · 2024 $2,989 · 2025 $3,385
Food & beverage: $3,155Education: $231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $556 |
| Janssen Biotech, Inc. | 21 | $483 |
| Novartis Pharmaceuticals Corporation | 19 | $481 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $400 |
| Galderma Laboratories, L.P. | 12 | $230 |
| Lilly USA, LLC | 11 | $204 |
| UCB, Inc. | 10 | $197 |
| Organon LLC | 12 | $172 |
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| E.R. Squibb & Sons, L.L.C. | 13 | $152 |
Products named: TREMFYA, SKYRIZI, COSENTYX, NEMLUVIO, ILUMYA, Bimzelx, DUPIXENT, RINVOQ.
Industry payments across TX — which companies pay providers there.
